2024-04-012025-03-312025-03-31false10427387SEMICONDUCTOR FILMS LTD2025-11-1790030falseiso4217:GBPxbrli:pure104273872024-03-31104273872025-03-31104273872024-04-012025-03-31104273872023-03-31104273872024-03-31104273872023-04-012024-03-3110427387bus:SmallEntities2024-04-012025-03-3110427387bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3110427387bus:FullAccounts2024-04-012025-03-3110427387bus:PrivateLimitedCompanyLtd2024-04-012025-03-3110427387core:WithinOneYear2025-03-3110427387core:AfterOneYear2025-03-3110427387core:WithinOneYear2024-03-3110427387core:AfterOneYear2024-03-3110427387core:ShareCapital2025-03-3110427387core:SharePremium2025-03-3110427387core:RevaluationReserve2025-03-3110427387core:OtherReservesSubtotal2025-03-3110427387core:RetainedEarningsAccumulatedLosses2025-03-3110427387core:ShareCapital2024-03-3110427387core:SharePremium2024-03-3110427387core:RevaluationReserve2024-03-3110427387core:OtherReservesSubtotal2024-03-3110427387core:RetainedEarningsAccumulatedLosses2024-03-3110427387core:LandBuildings2025-03-3110427387core:PlantMachinery2025-03-3110427387core:Vehicles2025-03-3110427387core:FurnitureFittings2025-03-3110427387core:OfficeEquipment2025-03-3110427387core:NetGoodwill2025-03-3110427387core:IntangibleAssetsOtherThanGoodwill2025-03-3110427387core:ListedExchangeTraded2025-03-3110427387core:UnlistedNon-exchangeTraded2025-03-3110427387core:LandBuildings2024-03-3110427387core:PlantMachinery2024-03-3110427387core:Vehicles2024-03-3110427387core:FurnitureFittings2024-03-3110427387core:OfficeEquipment2024-03-3110427387core:NetGoodwill2024-03-3110427387core:IntangibleAssetsOtherThanGoodwill2024-03-3110427387core:ListedExchangeTraded2024-03-3110427387core:UnlistedNon-exchangeTraded2024-03-3110427387core:LandBuildings2024-04-012025-03-3110427387core:PlantMachinery2024-04-012025-03-3110427387core:Vehicles2024-04-012025-03-3110427387core:FurnitureFittings2024-04-012025-03-3110427387core:OfficeEquipment2024-04-012025-03-3110427387core:NetGoodwill2024-04-012025-03-3110427387core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110427387core:ListedExchangeTraded2024-04-012025-03-3110427387core:UnlistedNon-exchangeTraded2024-04-012025-03-3110427387core:MoreThanFiveYears2024-04-012025-03-3110427387core:Non-currentFinancialInstruments2025-03-3110427387core:Non-currentFinancialInstruments2024-03-3110427387dpl:CostSales2024-04-012025-03-3110427387dpl:DistributionCosts2024-04-012025-03-3110427387core:LandBuildings2024-04-012025-03-3110427387core:PlantMachinery2024-04-012025-03-3110427387core:Vehicles2024-04-012025-03-3110427387core:FurnitureFittings2024-04-012025-03-3110427387core:OfficeEquipment2024-04-012025-03-3110427387dpl:AdministrativeExpenses2024-04-012025-03-3110427387core:NetGoodwill2024-04-012025-03-3110427387core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110427387dpl:GroupUndertakings2024-04-012025-03-3110427387dpl:ParticipatingInterests2024-04-012025-03-3110427387dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3110427387core:ListedExchangeTraded2024-04-012025-03-3110427387dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3110427387core:UnlistedNon-exchangeTraded2024-04-012025-03-3110427387dpl:CostSales2023-04-012024-03-3110427387dpl:DistributionCosts2023-04-012024-03-3110427387core:LandBuildings2023-04-012024-03-3110427387core:PlantMachinery2023-04-012024-03-3110427387core:Vehicles2023-04-012024-03-3110427387core:FurnitureFittings2023-04-012024-03-3110427387core:OfficeEquipment2023-04-012024-03-3110427387dpl:AdministrativeExpenses2023-04-012024-03-3110427387core:NetGoodwill2023-04-012024-03-3110427387core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3110427387dpl:GroupUndertakings2023-04-012024-03-3110427387dpl:ParticipatingInterests2023-04-012024-03-3110427387dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3110427387core:ListedExchangeTraded2023-04-012024-03-3110427387dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3110427387core:UnlistedNon-exchangeTraded2023-04-012024-03-3110427387core:NetGoodwill2025-03-3110427387core:IntangibleAssetsOtherThanGoodwill2025-03-3110427387core:LandBuildings2025-03-3110427387core:PlantMachinery2025-03-3110427387core:Vehicles2025-03-3110427387core:FurnitureFittings2025-03-3110427387core:OfficeEquipment2025-03-3110427387core:AfterOneYear2025-03-3110427387core:WithinOneYear2025-03-3110427387core:ListedExchangeTraded2025-03-3110427387core:UnlistedNon-exchangeTraded2025-03-3110427387core:ShareCapital2025-03-3110427387core:SharePremium2025-03-3110427387core:RevaluationReserve2025-03-3110427387core:OtherReservesSubtotal2025-03-3110427387core:RetainedEarningsAccumulatedLosses2025-03-3110427387core:NetGoodwill2024-03-3110427387core:IntangibleAssetsOtherThanGoodwill2024-03-3110427387core:LandBuildings2024-03-3110427387core:PlantMachinery2024-03-3110427387core:Vehicles2024-03-3110427387core:FurnitureFittings2024-03-3110427387core:OfficeEquipment2024-03-3110427387core:AfterOneYear2024-03-3110427387core:WithinOneYear2024-03-3110427387core:ListedExchangeTraded2024-03-3110427387core:UnlistedNon-exchangeTraded2024-03-3110427387core:ShareCapital2024-03-3110427387core:SharePremium2024-03-3110427387core:RevaluationReserve2024-03-3110427387core:OtherReservesSubtotal2024-03-3110427387core:RetainedEarningsAccumulatedLosses2024-03-3110427387core:NetGoodwill2023-03-3110427387core:IntangibleAssetsOtherThanGoodwill2023-03-3110427387core:LandBuildings2023-03-3110427387core:PlantMachinery2023-03-3110427387core:Vehicles2023-03-3110427387core:FurnitureFittings2023-03-3110427387core:OfficeEquipment2023-03-3110427387core:AfterOneYear2023-03-3110427387core:WithinOneYear2023-03-3110427387core:ListedExchangeTraded2023-03-3110427387core:UnlistedNon-exchangeTraded2023-03-3110427387core:ShareCapital2023-03-3110427387core:SharePremium2023-03-3110427387core:RevaluationReserve2023-03-3110427387core:OtherReservesSubtotal2023-03-3110427387core:RetainedEarningsAccumulatedLosses2023-03-3110427387core:AfterOneYear2024-04-012025-03-3110427387core:WithinOneYear2024-04-012025-03-3110427387core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3110427387core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3110427387core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3110427387core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3110427387core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3110427387core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3110427387core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110427387core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110427387core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110427387core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3110427387core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3110427387core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3110427387core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3110427387core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3110427387core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3110427387core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3110427387core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3110427387core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3110427387core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3110427387core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3110427387core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3110427387core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3110427387core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3110427387core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3110427387core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3110427387core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3110427387core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3110427387bus:Director12024-04-012025-03-3110427387bus:Director22024-04-012025-03-31

SEMICONDUCTOR FILMS LTD

Registered Number
10427387
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

SEMICONDUCTOR FILMS LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

JARMAN, Ruth
GERHARDT, Joseph

Registered Address

7 Franklin Street
Brighton
BN2 3AL

Registered Number

10427387 (England and Wales)
SEMICONDUCTOR FILMS LTD
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets34,2655,686
4,2655,686
Current assets
Debtors9141,336
Cash at bank and on hand21,62651,301
22,54052,637
Creditors amounts falling due within one year4(5,917)(47,623)
Net current assets (liabilities)16,6235,014
Total assets less current liabilities20,88810,700
Provisions for liabilities5(810)(1,080)
Net assets20,0789,620
Capital and reserves
Called up share capital11
Profit and loss account20,0779,619
Shareholders' funds20,0789,620
The financial statements were approved and authorised for issue by the Board of Directors on 17 November 2025, and are signed on its behalf by:
JARMAN, Ruth
Director
Registered Company No. 10427387
SEMICONDUCTOR FILMS LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
The directors have assessed whether the going concern basis of preparation continues to be appropriate, based on whether there are any material uncertainties related to events or conditions that may cast significant doubt on the ability of the company to continue as a going concern. At the time of approving the financial statements the directors believe that all appropriate measures have been or will be taken to ensure that the company will be able to continue its operations for at least the next 12 months and thus conclude that the going concern basis remains appropriate.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Research and development
All research costs are expensed. Costs related to the development of products are capitalised when they meet the criteria stated in FRS 102, Section 18 Intangible assets other than Goodwill. All other development expenditure is recognised as an expense in the period in which it is incurred.
Development costs
Capitalised development costs, where reognised, are stated at cost less accumulated amortisation and accumulated impairment losses (cost model). Amortisation is recognised using the straight-line basis and results in the carrying amount being expensed in profit or loss over the estimated useful life.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery25
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Government grants or assistance
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss. Where a Grant is ring fenced for specific expenditure, the income on these Grants is matched against the expenditure when it is incurred. Arts Council and other grants received for Research and Development are included in other operating income - the income is recognised when the expenditure is incurred.
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
At 01 April 2425,90825,908
At 31 March 2525,90825,908
Depreciation and impairment
At 01 April 2420,22220,222
Charge for year1,4221,422
Other adjustments(1)(1)
At 31 March 2521,64321,643
Net book value
At 31 March 254,2654,265
At 31 March 245,6865,686
4.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables-2,095
Other creditors4,3733,749
Accrued liabilities and deferred income1,54441,779
Total5,91747,623
5.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)8101,080
Total8101,080